MICHELLE KEUNG: Open Payments
NPI 1730864992 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,678 in 153 payments from 16 companies in 2025. Trend: 2023 $102 · 2024 $462 · 2025 $2,678
Food & beverage: $2,678
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 38 | $725 |
| ABBVIE INC. | 38 | $531 |
| QOL Medical, LLC | 10 | $211 |
| Janssen Biotech, Inc. | 13 | $173 |
| Madrigal Pharmaceuticals | 7 | $163 |
| PFIZER INC. | 4 | $148 |
| Aimmune Therapeutics, Inc. | 11 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $83 |
Products named: XIFAXAN, RINVOQ, Sucraid, TREMFYA, REZDIFFRA, DUPIXENT, ZENPEP, VELSIPITY.
Industry payments across CA — which companies pay providers there.
